Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical changes in how the liver and kidneys process therapeutic drugs. The experimental technology, under development at the University of California, Los Angeles, aims to overcome longstanding limitations that have hindered wearable microneedle biosensors.
This article was originally published on MedicalXpress.com

